JNJ logo

Johnson & Johnson (JNJ)

Profile

Full Name

Johnson & Johnson

Ticker Symbol

JNJ

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

January 2, 1943

Indexes

S&P 500,Dow Jones

Website

http://www.jnj.com

Employees

138100

Key Details

Price

$155.92(+2.08%)

Market cap

$375.15B(Mega cap)

Last Dividend

$1.30

TTM Dividend yield

3.22%

Annual revenue

$88.82B(+4.30% YoY)

Annual EPS

$5.79(-57.80% YoY)

PE ratio

17.34

Next earnings date

Jul 16, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $155.92
    JNJ price is $155.92

    30-Day Relative Volume

    1.31
    JNJ 30-day relative volume is 1.31

    Price Performance

    Price Most recent change

    +2.08%
    JNJ price was up +2.08% on Jul 1, 2025

    Price YTD change

    +7.81%
    JNJ price is up +7.81% since January 1st

    Price 1-year change

    +6.47%
    JNJ price is up +6.47% year-on-year

    Price 3-year change

    -13.15%
    JNJ price is down -13.15% over the past 3 years

    Price Range

    Price All-time high

    $186.69
    JNJ price is currently -16.48% below its historical high of $186.69

    Price 3-year low

    $140.68
    JNJ price is currently +10.83% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $375.15B
    JNJ market capitalization is $375.15 billion

    Market cap 3-year change

    -20.58%
    JNJ market capitalization is down -20.58% over the past 3 years

    Market cap All-time high

    $489.47B
    JNJ market capitalization is currently -23.35% below its historical high of $489.47 billion

    Market cap sector rank

    99.92%
    JNJ market capitalization is higher than 99.92% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.03%
    JNJ shares outstanding is down -0.03% year-on-year

    Shares Outstanding 3-Year Change

    -8.56%
    JNJ shares outstanding is down -8.56% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.01
    JNJ beta is 0.01

    200-day SMA

    $155.61
    JNJ price is currently +0.20% above its 200-day simple moving average

    50-day SMA

    $153.86
    JNJ price is currently +1.34% above its 50-day simple moving average

    RSI

    57.90
    JNJ 14-day relative strength index is 57.90

    Volume

    1.31
    JNJ 30-day relative volume is 1.31

    ATR

    $2.35
    JNJ average true range is $2.35

    10-day Historical Volatility

    17.26%
    JNJ 10-day historical volatility is 17.26%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $1.30
    JNJ last dividend was $1.30 per share, with an ex-dividend date of May 27, 2025

    Next Dividend

    -
    JNJ next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $4.91
    JNJ annual dividend per share is $4.91

    Dividend per share Sector Rank

    90.59%
    JNJ annual dividend per share is higher than 90.59% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +4.47%
    JNJ annual dividend per share is up +4.47% year-on-year

    Dividend per share 3-Year Change

    +17.18%
    JNJ annual dividend per share is up +17.18% over the past 3 years

    Dividend yield

    Dividend yield

    3.15%
    JNJ annual dividend yield is 3.15%

    Dividend yield Sector Rank

    70.24%
    JNJ annual dividend yield is higher than 70.24% of companies in Healthcare sector

    Other

    Payout ratio

    84.05%
    JNJ annual payout ratio is 84.05%

    Dividends paid

    $11.82B
    JNJ annual dividends paid is $11.82 billion

    Free cash flow

    $18.06B
    JNJ annual free cash flow is $18.06 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $88.82B
    JNJ annual revenue is $88.82 billion

    Revenue Analysts estimate

    $91.30B
    JNJ annual revenue is currently -2.71% lower than the consensus analysts' forecast

    Revenue 1-year change

    +4.3%
    JNJ annual revenue is up +4.3% year-on-year

    Revenue Sector rank

    98.87%
    JNJ annual revenue is higher than 98.87% of companies in Healthcare sector

    EPS

    EPS

    $5.79
    JNJ annual earnings per share is $5.79

    EPS Analysts estimate

    $10.61
    JNJ annual earnings per share is currently -45.41% lower than the consensus analysts' forecast

    EPS 1-year change

    -57.8%
    JNJ annual earnings per share is down -57.8% year-on-year

    EPS Sector rank

    96.13%
    JNJ annual earnings per share is higher than 96.13% of companies in Healthcare sector

    Profit

    Gross profit

    $61.35B
    JNJ annual gross profit is $61.35 billion

    Gross margin

    69.07%
    JNJ annual gross profit margin is 69.07%

    Operating profit

    $21.25B
    JNJ annual operating income is $21.25 billion

    Operating margin

    23.92%
    JNJ annual operating profit margin is 23.92%

    Net income

    $14.07B
    JNJ annual net profit is $14.07 billion

    Net margin

    15.84%
    JNJ annual net profit margin is 15.84%

    Expenses

    Total expenses

    $67.57B
    JNJ annual total expenses is $67.57 billion

    Operating expenses

    $40.10B
    JNJ annual total operating expenses is $40.10 billion

    Cost of goods sold

    $27.47B
    JNJ annual cost of goods sold is $27.47 billion

    Selling, general & administrative expenses

    $22.87B
    JNJ annual SGA is $22.87 billion

    Depreciation and amortization

    $7.34B
    JNJ annual depreciation & amortization is $7.34 billion

    Interest expense

    $755.00M
    JNJ annual interest expense is $755.00 million

    Income tax

    $2.62B
    JNJ annual income tax is $2.62 billion

    EBIT & EBITDA

    EBIT

    $21.25B
    JNJ annual earnings before interest & taxes is $21.25 billion

    EBITDA

    $21.25B
    JNJ annual EBITDA is $21.25 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $180.10B
    JNJ annual total assets is $180.10 billion

    Non current assets

    $124.21B
    JNJ annual long term assets is $124.21 billion

    Current assets

    $55.89B
    JNJ annual total current assets is $55.89 billion

    Cash and cash equivalents

    $24.11B
    JNJ annual cash & cash equivalents is $24.11 billion

    Accounts receivable

    $14.84B
    JNJ annual accounts receivable is $14.84 billion

    Inventory

    $12.44B
    JNJ annual inventory is $12.44 billion

    Liabilities

    Total liabilities

    $108.61B
    JNJ annual total liabilities is $108.61 billion

    Long term liabilities

    $58.29B
    JNJ annual total long term liabilities is $58.29 billion

    Current liabilities

    $50.32B
    JNJ annual total current liabilities is $50.32 billion

    Accounts payable

    $10.31B
    JNJ annual accounts payable is $10.31 billion

    Debt

    Total debt

    $36.63B
    JNJ annual total debt is $36.63 billion

    Total debt 1-year change

    +24.89%
    JNJ annual total debt is up +24.89% year-on-year

    Long term debt

    $30.65B
    JNJ annual long term debt is $30.65 billion

    Short term debt

    $5.98B
    JNJ annual short term debt is $5.98 billion

    Equity & Capital

    Shareholders equity

    $71.49B
    JNJ annual stockholders equity is $71.49 billion

    Book value

    $71.49B
    JNJ annual book value is $71.49 billion

    Retained earnings

    -
    JNJ annual retained earnings value is unknown

    Working capital

    $5.57B
    JNJ annual working capital is $5.57 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $24.27B
    JNJ annual cash flow from operations is $24.27 billion

    Cash from operations 1-year change

    +6.47%
    JNJ annual cash flow from operations is up +6.47% year-on-year

    Cash from investing

    -$18.60B
    JNJ annual cash flow from investing activities is -$18.60 billion

    Cash from investing 1-year change

    -2218.34%
    JNJ annual cash flow from investing activities is down -2218.34% year-on-year

    Cash from financing

    -$3.13B
    JNJ annual cash flow from financing activities is -$3.13 billion

    Cash from financing 1-year change

    +80.21%
    JNJ annual cash flow from financing activities is up +80.21% year-on-year

    CAPEX

    CAPEX

    $6.21B
    JNJ annual capital expenditures is $6.21 billion

    CAPEX 1-year change

    +23.82%
    JNJ annual capital expenditures is up +23.82% year-on-year

    Free Cash Flow

    Free cash flow

    $18.06B
    JNJ annual free cash flow is $18.06 billion

    Free cash flow 1-year change

    +1.58%
    JNJ annual free cash flow is up +1.58% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    69.07%
    JNJ annual gross profit margin is 69.07%

    Operating margin

    23.92%
    JNJ annual operating profit margin is 23.92%

    Net margin

    15.84%
    JNJ annual net profit margin is 15.84%

    ROA & ROE

    ROA

    8.09%
    JNJ annual return on assets is 8.09%

    ROE

    20.06%
    JNJ annual return on equity is 20.06%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    17.34
    JNJ price to earnings ratio is 17.34

    PE ratio Sector rank

    35.98%
    JNJ price to earnings ratio is higher than 35.98% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.80
    JNJ price to book ratio is 4.80

    PB ratio Sector rank

    80.26%
    JNJ price to book ratio is higher than 80.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.20
    JNJ price to sales ratio is 4.20

    PS ratio Sector rank

    59.6%
    JNJ price to sales ratio is higher than 59.6% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $388.93B
    JNJ enterprise value is $388.93 billion

    Enterprise value Sector rank

    99.83%
    JNJ enterprise value is higher than 99.83% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    15.38
    JNJ EV/EBITDA is 15.38

    EV/EBITDA Sector rank

    88.85%
    JNJ EV/EBITDA is higher than 88.85% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.11
    JNJ annual current ratio is 1.11

    Quick ratio

    0.86
    JNJ annual quick ratio is 0.86

    Leverage

    Debt to equity

    0.51
    JNJ annual debt to equity ratio is 0.51

    Interest coverage ratio

    28.14
    JNJ annual interest coverage ratio is 28.14

    Risk & Stability

    Piotroski F-Score

    5
    JNJ piotroski f-score is 5

    Altman Z-Score

    -
    JNJ altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 13, 25 Leerink Partners
    Market Perform
    Apr 17, 25 Barclays
    Equal-Weight
    Apr 16, 25 Raymond James
    Outperform
    Apr 16, 25 RBC Capital
    Outperform
    Apr 16, 25 Morgan Stanley
    Equal-Weight
    Apr 14, 25 Raymond James
    Outperform
    Apr 10, 25 B of A Securities
    Neutral
    Apr 9, 25 Morgan Stanley
    Equal-Weight
    Apr 9, 25 Goldman Sachs
    Buy
    Apr 3, 25 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with JNJ included

    US stocks
    S&P 500 companies earnings calendar
    Most recommended stocks
    Best performing stocks last 5 years
    Dow Jones companies
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Stocks ready to break out
    Healthcare sector
    • What is the ticker symbol for Johnson & Johnson?
    • Does Johnson & Johnson pay dividends?
    • What sector is Johnson & Johnson in?
    • What industry is Johnson & Johnson in?
    • What country is Johnson & Johnson based in?
    • When did Johnson & Johnson go public?
    • Is Johnson & Johnson in the S&P 500?
    • Is Johnson & Johnson in the NASDAQ 100?
    • Is Johnson & Johnson in the Dow Jones?
    • When was Johnson & Johnson's last earnings report?
    • When does Johnson & Johnson report earnings?
    • Should I buy Johnson & Johnson stock now?

    What is the ticker symbol for Johnson & Johnson?

    The ticker symbol for Johnson & Johnson is NYSE:JNJ

    Does Johnson & Johnson pay dividends?

    Yes, Johnson & Johnson pays dividends. The last payment was $1.30, with an ex-dividend date on May 27, 2025

    What sector is Johnson & Johnson in?

    Johnson & Johnson is in the Healthcare sector

    What industry is Johnson & Johnson in?

    Johnson & Johnson is in the Drug Manufacturers - General industry

    What country is Johnson & Johnson based in?

    Johnson & Johnson is headquartered in United States

    When did Johnson & Johnson go public?

    Johnson & Johnson's initial public offering (IPO) was on January 2, 1943

    Is Johnson & Johnson in the S&P 500?

    Yes, Johnson & Johnson is included in the S&P 500 index

    Is Johnson & Johnson in the NASDAQ 100?

    No, Johnson & Johnson is not included in the NASDAQ 100 index

    Is Johnson & Johnson in the Dow Jones?

    Yes, Johnson & Johnson is included in the Dow Jones index

    When was Johnson & Johnson's last earnings report?

    Johnson & Johnson's most recent earnings report was on Apr 15, 2025

    When does Johnson & Johnson report earnings?

    The next expected earnings date for Johnson & Johnson is Jul 16, 2025

    Should I buy Johnson & Johnson stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page